Pluri Inc.
PLUR
$4.72
$0.11412.48%
Weiss Ratings | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.09 | |||
Price History | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.09% | |||
30-Day Total Return | 4.98% | |||
60-Day Total Return | 3.71% | |||
90-Day Total Return | 3.60% | |||
Year to Date Total Return | 9.10% | |||
1-Year Total Return | -37.51% | |||
2-Year Total Return | -28.84% | |||
3-Year Total Return | -71.61% | |||
5-Year Total Return | -81.07% | |||
52-Week High % Change | -43.76% | |||
52-Week Low % Change | 16.07% | |||
Price | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $8.40 | |||
52-Week Low Price | $4.07 | |||
52-Week Low Price (Date) | Dec 31, 2024 | |||
52-Week High Price (Date) | Mar 26, 2024 | |||
Valuation | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 33.06M | |||
Enterprise Value | 46.15M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -3.69 | |||
Earnings Per Share Growth | -21.41% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 38.72 | |||
Price/Book (Q) | -3.27 | |||
Enterprise Value/Revenue (TTM) | 68.07 | |||
Price | $4.72 | |||
Enterprise Value/EBITDA (TTM) | -2.15 | |||
Enterprise Value/EBIT | -2.12 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 5.55M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 74 710 8600 | |||
Address | -- | |||
Website | www.pluri-biotech.com | |||
Country | Israel | |||
Year Founded | 2001 | |||
Profitability | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -3,203.98% | |||
Profit Margin | -2,929.20% | |||
Management Effectiveness | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -37.49% | |||
Return on Equity | -- | |||
Income Statement | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 678.00K | |||
Total Revenue (TTM) | 678.00K | |||
Revenue Per Share | $0.12 | |||
Gross Profit (TTM) | 474.00K | |||
EBITDA (TTM) | -21.47M | |||
EBIT (TTM) | -21.72M | |||
Net Income (TTM) | -19.86M | |||
Net Income Avl. to Common (TTM) | -19.86M | |||
Total Revenue Growth (Q YOY) | 76.19% | |||
Earnings Growth (Q YOY) | 37.73% | |||
EPS Diluted (TTM) | -3.69 | |||
EPS Diluted Growth (Q YOY) | 43.67% | |||
Balance Sheet | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 21.31M | |||
Cash Per Share (Q) | $3.84 | |||
Total Current Assets (Q) | 22.37M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -2.92M | |||
Current Ratio (Q) | 5.038 | |||
Book Value Per Share (Q) | -$1.44 | |||
Total Assets (Q) | 30.86M | |||
Total Current Liabilities (Q) | 4.44M | |||
Total Debt (Q) | 29.30M | |||
Total Liabilities (Q) | 33.78M | |||
Total Common Equity (Q) | -8.03M | |||
Cash Flow | PLUR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 10.09M | |||
Cash from Financing (TTM) | 8.84M | |||
Net Change in Cash (TTM) | 1.80M | |||
Levered Free Cash Flow (TTM) | -11.84M | |||
Cash from Operations (TTM) | -17.21M | |||